Table of Contents Author Guidelines Submit a Manuscript
Advances in Hematology
Volume 2011, Article ID 736261, 10 pages
http://dx.doi.org/10.1155/2011/736261
Review Article

Clinical, Molecular, and Environmental Risk Factors for Hodgkin Lymphoma

Winship Cancer Institute, Emory University, Atlanta, GA 30322, USA

Received 2 July 2010; Accepted 11 October 2010

Academic Editor: Meral Beksac

Copyright © 2011 Alison Maggioncalda et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. A. Rosenberg and H. S. Kaplan, “Evidence for an orderly progression in the spread of Hodgkin's disease,” Cancer Research, vol. 26, no. 6, pp. 1225–1231, 1966. View at Google Scholar · View at Scopus
  2. S. L. Glaser, C. A. Clarke, and C. A. Clarke, “Population-based patterns of human immunodeficiency virus-related Hodgkin lymphoma in the greater San Francisco bay area, 1988–1998,” Cancer, vol. 98, no. 2, pp. 300–309, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. American Cancer Society, Cancer Facts & Figures, 2010.
  4. S. Altekruse, C. Kosary, and M. Krapcho, Eds., SEER Cancer Statistics Review, National Cancer Institute, Bethesda, Md, USA, 2010.
  5. A. Punnett, R. W. Tsang, and D. C. Hodgson, “Hodgkin lymphoma across the age spectrum: epidemiology, therapy, and late effects,” Seminars in Radiation Oncology, vol. 20, no. 1, pp. 30–44, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. B. Schnitzer, “Hodgkin lymphoma,” Hematology/Oncology Clinics of North America, vol. 23, no. 4, pp. 747–768, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  7. R. Küppers, “The biology of Hodgkin's lymphoma,” Nature Reviews Cancer, vol. 9, no. 1, pp. 15–27, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  8. V. Aldred, J. Vassallo, A. H. J. Froes M. Campos, and F. Augusto Soares, “CD20 expression by Hodgkin-Reed-Sternberg cells in classical Hodgkin lymphoma is related to reduced overall survival in young adult patients,” Leukemia and Lymphoma, vol. 49, no. 11, pp. 2198–2202, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. S. Mathas, M. Janz, and M. Janz, “Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma,” Nature Immunology, vol. 7, no. 2, pp. 207–215, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. R. Küppers, U. Klein, and U. Klein, “Identification of Hodgkin and Reed-Sternberg cell-specific genes by gene expression profiling,” Journal of Clinical Investigation, vol. 111, no. 4, pp. 529–537, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. C. Renné, J. I. Martin-Subero, M. Eickernjäger, M.-L. Hansmann, R. Küppers, R. Siebert, and A. Bräuninger, “Aberrant expression of ID2, a suppressor of B-cell-specific gene expression, in Hodgkin's lymphoma,” American Journal of Pathology, vol. 169, no. 2, pp. 655–664, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. H.-D. Foss, R. Reusch, G. Demel, G. Lenz, I. Anagnostopoulos, M. Hummel, and H. Stein, “Frequent expression of the B-cell-specific activator protein in Reed- Sternberg cells of classical Hodgkin's disease provides further evidence for its B-cell origin,” Blood, vol. 94, no. 9, pp. 3108–3113, 1999. View at Google Scholar · View at Scopus
  13. R. T. Hoppe, H. A. Ranjana, and Z. A. Weiyun, “Hodgkin lymphoma,” NCCN Clinical Practice Guidelines in Oncology, vol. 1, no. 47, 2010. View at Google Scholar
  14. V. T. Devita Jr., A. A. Serpick, and P. P. Carbone, “Combination chemotherapy in the treatment of advanced Hodgkin's disease,” Annals of Internal Medicine, vol. 73, no. 6, pp. 881–895, 1970. View at Google Scholar · View at Scopus
  15. B. Macmahon, “Epidemiological evidence of the nature of Hodgkin's disease,” Cancer, vol. 10, no. 5, pp. 1045–1054, 1957. View at Google Scholar
  16. H. Hjalgrim, A. Seow, K. Rostgaard, and J. Friborg, “Changing patterns of Hodgkin lymphoma incidence in Singapore,” International Journal of Cancer, vol. 123, no. 3, pp. 716–719, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  17. P. Pahwa, C. P. Karunanayake, J. J. Spinelli, J. A. Dosman, and H. H. McDuffie, “Ethnicity and incidence of Hodgkin lymphoma in Canadian population,” BMC Cancer, vol. 9, article 141, 2009. View at Publisher · View at Google Scholar · View at PubMed
  18. E. T. Chang, T. Zheng, E. G. Weir, M. Borowitz, R. B. Mann, D. Spiegelman, and N. E. Mueller, “Childhood social environment and Hodgkin's lymphoma: new findings from a population-based case-control study,” Cancer Epidemiology Biomarkers and Prevention, vol. 13, no. 8, pp. 1361–1370, 2004. View at Google Scholar
  19. C. P. Karunanayake, G. V. Singh, J. J. Spinelli, J. R. McLaughlin, J. A. Dosman, H. H. McDuffie, and P. Pahwa, “Occupational exposures and hodgkin lymphoma: Canadian case-control study,” Journal of Occupational and Environmental Medicine, vol. 51, no. 12, pp. 1447–1454, 2009. View at Publisher · View at Google Scholar · View at PubMed
  20. W. Cozen, A. S. Hamilton, and A. S. Hamilton, “A protective role for early oral exposures in the etiology of young adult Hodgkin lymphoma,” Blood, vol. 114, no. 19, pp. 4014–4020, 2009. View at Publisher · View at Google Scholar · View at PubMed
  21. S. L. Glaser, T. H. M. Keegan, and T. H. M. Keegan, “Smoking and Hodgkin lymphoma risk in women United States,” Cancer Causes and Control, vol. 15, no. 4, pp. 387–397, 2004. View at Publisher · View at Google Scholar · View at PubMed
  22. T. H. M. Keegan, S. L. Glaser, and S. L. Glaser, “Body size, physical activity, and risk of Hodgkin's lymphoma in women,” Cancer Epidemiology Biomarkers and Prevention, vol. 15, no. 6, pp. 1095–1101, 2006. View at Publisher · View at Google Scholar · View at PubMed
  23. E. T. Chang, D. P. Cronin-Fenton, S. Friis, H. Hjalgrim, H. T. Sørensen, and L. Pedersen, “Aspirin and other nonsteroidal anti-inflammatory drugs in relation to Hodgkin lymphoma risk in Northern Denmark,” Cancer Epidemiology Biomarkers and Prevention, vol. 19, no. 1, pp. 59–64, 2010. View at Publisher · View at Google Scholar · View at PubMed
  24. N. C. Briggs, H. Irene Hall, E. A. Brann, C. J. Moriarty, and R. S. Levine, “Cigarette smoking and risk of Hodgkin's disease: a population-based case-control study,” American Journal of Epidemiology, vol. 156, no. 11, pp. 1011–1020, 2002. View at Publisher · View at Google Scholar
  25. E. T. Chang, B. M. Birmann, and B. M. Birmann, “Polymorphic variation in NFKB1 and other aspirin-related genes and risk of Hodgkin lymphoma,” Cancer Epidemiology Biomarkers and Prevention, vol. 18, no. 3, pp. 976–986, 2009. View at Publisher · View at Google Scholar · View at PubMed
  26. V. Mollaki, T. Georgiadis, and T. Georgiadis, “Polymorphisms and haplotypes in TLR9 and MYD88 are associated with the development of Hodgkin's lymphoma: a candidate-gene association study,” Journal of Human Genetics, vol. 54, no. 11, pp. 655–659, 2009. View at Publisher · View at Google Scholar · View at PubMed
  27. S. Ariad, I. Lipshitz, D. Benharroch, J. Gopas, and M. Barchana, “A sharp rise in the incidence of Hodgkin's lymphoma in young adults in Israel,” Israel Medical Association Journal, vol. 11, no. 8, pp. 453–455, 2009. View at Google Scholar
  28. A. Levy, V. Diomin, J. Gopas, S. Ariad, M. Sacks, and D. Benharroch, “Hodgkin's lymphoma in the Bedouin of southern Israel: epidemiological and clinical features,” Israel Medical Association Journal, vol. 2, no. 7, pp. 501–503, 2000. View at Google Scholar
  29. G. S. Pinheiro, M. R. R. Silva, C. A. Rodrigues, J. Kerbauy, and J. S. R. de Oliveira, “Proliferating cell nuclear antigen (PCNA), p53 and MDM2 expression in Hodgkins disease,” Sao Paulo Medical Journal, vol. 125, no. 2, pp. 77–84, 2007. View at Google Scholar
  30. S. L. Glaser and J. L. Hsu, “Hodgkin's disease in Asians: incidence patterns and risk factors in population-based data,” Leukemia Research, vol. 26, no. 3, pp. 261–269, 2002. View at Publisher · View at Google Scholar
  31. K. J. Flavell, J. P. Biddulph, and J. P. Biddulph, “South Asian ethnicity and material deprivation increase the risk of Epstein-Barr virus infection in childhood Hodgkin's disease,” British Journal of Cancer, vol. 85, no. 3, pp. 350–356, 2001. View at Publisher · View at Google Scholar · View at PubMed
  32. P. Phillimore, A. Beattie, and P. Townsend, “Widening inequality of health in northern England, 1981–91,” British Medical Journal, vol. 308, no. 6937, pp. 1125–1128, 1994. View at Google Scholar
  33. N. Roswall, A. Olsen, J. Christensen, K. Rugbjerg, and L. Mellemkjær, “Social inequality and incidence of and survival from Hodgkin lymphoma, non-Hodgkin lymphoma and leukaemia in a population-based study in Denmark, 1994–2003,” European Journal of Cancer, vol. 44, no. 14, pp. 2058–2073, 2008. View at Publisher · View at Google Scholar · View at PubMed
  34. A. Soares, I. Biasoli, and I. Biasoli, “Socioeconomic inequality and short-term outcome in Hodgkin's lymphoma,” International Journal of Cancer, vol. 120, no. 4, pp. 875–879, 2007. View at Publisher · View at Google Scholar · View at PubMed
  35. F. D. Martinez and P. G. Holt, “Role of microbial burden in aetiology of allergy and asthma,” Lancet, vol. 354, no. 2, pp. SII12–SII15, 1999. View at Google Scholar
  36. P. M. Matricardi and S. Bonini, “High microbial turnover rate preventing atopy: a solution to inconsistencies impinging on the Hygiene hypothesis?” Clinical and Experimental Allergy, vol. 30, no. 11, pp. 1506–1510, 2000. View at Publisher · View at Google Scholar
  37. B. F. Skinnider and T. W. Mak, “The role of cytokines in classical Hodgkin lymphoma,” Blood, vol. 99, no. 12, pp. 4283–4297, 2002. View at Publisher · View at Google Scholar · View at PubMed
  38. P. L. Amlot and L. A. Green, “Atopy and immunoglobulin E concentrations in Hodgkin's disease and other lymphomas,” British Medical Journal, vol. 1, no. 6109, pp. 327–329, 1978. View at Google Scholar
  39. T. M. Mack, D. Deapen, and A. S. Hamilton, “Representativeness of a roster of volunteer North American twins with chronic disease,” Twin Research, vol. 3, no. 1, pp. 33–42, 2000. View at Google Scholar
  40. D. Gunnell, “Height, insulin-like growth factors and cancer risk,” Growth Hormone and IGF Research, vol. 10, pp. S39–S40, 2000. View at Google Scholar
  41. A. Monnereau, L. Orsi, and L. Orsi, “Cigarette smoking, alcohol drinking, and risk of lymphoid neoplasms: Results of a French case-control study,” Cancer Causes and Control, vol. 19, no. 10, pp. 1147–1160, 2008. View at Publisher · View at Google Scholar · View at PubMed
  42. R. F. Ambinder, “Epstein-barr virus and hodgkin lymphoma,” Hematology, pp. 204–209, 2007. View at Google Scholar
  43. S. L. Glaser, R. J. Lin, and R. J. Lin, “Epstein-Barr virus-associated Hodgkin's disease: epidemiologic characteristics in international data,” International Journal of Cancer, vol. 70, no. 4, pp. 375–382, 1997. View at Publisher · View at Google Scholar
  44. D. H. Crawford, K. F. Macsween, and K. F. Macsween, “A cohort study among university students: identification of risk factors for Epstein-Barr virus seroconversion and infectious mononucleosis,” Clinical Infectious Diseases, vol. 43, no. 3, pp. 276–282, 2006. View at Publisher · View at Google Scholar · View at PubMed
  45. H. Hjalgrim, K. E. Smedby, and K. E. Smedby, “Infectious mononucleosis, childhood social environment, and risk of Hodgkin lymphoma,” Cancer Research, vol. 67, no. 5, pp. 2382–2388, 2007. View at Publisher · View at Google Scholar · View at PubMed
  46. R. Küppers, “Molecular biology of Hodgkin lymphoma,” Hematology, pp. 491–496, 2009. View at Google Scholar
  47. E. Kilger, A. Kieser, M. Baumann, and W. Hammerschmidt, “Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor,” EMBO Journal, vol. 17, no. 6, pp. 1700–1709, 1998. View at Publisher · View at Google Scholar · View at PubMed
  48. C. Mancao and W. Hammerschmidt, “Epstein-Barr virus latent membrane protein 2A is a B-cell receptor mimic and essential for B-cell survival,” Blood, vol. 110, no. 10, pp. 3715–3721, 2007. View at Publisher · View at Google Scholar · View at PubMed
  49. A. Bräuninger, R. Schmitz, D. Bechtel, C. Renné, M.-L. Hansmann, and R. Küppers, “Molecular biology of Hodgkin's and Reed/Sternberg cells in Hodgkin's lymphoma,” International Journal of Cancer, vol. 118, no. 8, pp. 1853–1861, 2006. View at Publisher · View at Google Scholar · View at PubMed
  50. D. Bechtel, J. Kurth, C. Unkel, and R. Küppers, “Transformation of BCR-deficient germinal-center B cells by EBV supports a major role of the virus in the pathogenesis of Hodgkin and posttransplantation lymphomas,” Blood, vol. 106, no. 13, pp. 4345–4350, 2005. View at Publisher · View at Google Scholar · View at PubMed
  51. S. Chaganti, A. I. Bell, N. B. Pastor, A. E. Milner, M. Drayson, J. Gordon, and A. B. Rickinson, “Epstein-Barr virus infection in vitro can rescue germinal center B cells with inactivated immunoglobulin genes,” Blood, vol. 106, no. 13, pp. 4249–4252, 2005. View at Publisher · View at Google Scholar · View at PubMed
  52. R. Schmitz, M.-L. Hansmann, and M.-L. Hansmann, “TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma,” Journal of Experimental Medicine, vol. 206, no. 5, pp. 981–989, 2009. View at Publisher · View at Google Scholar · View at PubMed
  53. T. H. M. Keegan, S. L. Glaser, and S. L. Glaser, “Epstein-Barr virus as a marker of survival after Hodgkin's lymphoma: a population-based study,” Journal of Clinical Oncology, vol. 23, no. 30, pp. 7604–7613, 2005. View at Publisher · View at Google Scholar · View at PubMed
  54. R. J. Biggar, E. S. Jaffe, J. J. Goedert, A. Chaturvedi, R. Pfeiffer, and E. A. Engels, “Hodgkin lymphoma and immunodeficiency in persons with HIV/AIDS,” Blood, vol. 108, no. 12, pp. 3786–3791, 2006. View at Publisher · View at Google Scholar · View at PubMed
  55. B. Chetaille, F. Bertucci, and F. Bertucci, “Molecular profiling of classical Hodgkin lymphoma tissues uncovers variations in the tumor microenvironment and correlations with EBV infection and outcome,” Blood, vol. 113, no. 12, pp. 2765–2775, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  56. H. Hjalgrim, K. Rostgaard, and K. Rostgaard, “HLA-A alleles and infectious mononucleosis suggest a critical role for cytotoxic T-cell response in EBV-related Hodgkin lymphoma,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 14, pp. 6400–6405, 2010. View at Publisher · View at Google Scholar · View at PubMed
  57. P. J. Shenoy, A. Maggioncalda, N. Malik, and C. R. Flowers, “Incidence patterns and outcomes for Hodgkin lymphoma patients in the United States,” Advances in Hematology, 2010 (in press).